NDI draft guidance comments

NPA to FDA: Ditch product-specific notifications and accept our grandfathered lists … and NDI guidance could be salvaged

By Elaine Watson

- Last updated on GMT

NPA: "The draft guidance completely eviscerates the food additive prohibitions that Congress so carefully placed in the Dietary Supplement Health and Education Act and also contravenes the deep-rooted DSHEA policy in favor of consumer freedowm of choice and support for smaller businesses."
NPA: "The draft guidance completely eviscerates the food additive prohibitions that Congress so carefully placed in the Dietary Supplement Health and Education Act and also contravenes the deep-rooted DSHEA policy in favor of consumer freedowm of choice and support for smaller businesses."
The Food and Drug Administration’s (FDA’s) draft guidance on new dietary ingredients (NDIs) can be salvaged, but only if the agency is willing to substantially rewrite the offending document, the Natural Products Association (NPA) has argued.

The first trade association to submit comments to the docket about the guidance ahead of tomorrow’s deadline, the NPA has drawn up a succinct 11-point action plan detailing what it believes the FDA needs to do to turn its July 5 draft into something the industry can work with.

FDA should make clear that it is not making enforcement decisions based on the draft guidance

In a 17-page submission signed by NPA chief executive John Gay and scientific and regulatory affairs chief Cara Welch, the NPA also urges the FDA to “make clear that it is not already following this draft guidance when making enforcement decisions”​.

Ultimately, says the NPA, the industry asked for guidance on NDIs and welcomes the fact that the FDA has - 17 years later - finally provided it.

But the net result has been a document that “sets up inappropriate barriers to entry, imposes food additive criteria and requires multiple NDI notifications for dietary supplements beyond those required by law” ​– and will have a “chilling” ​effect on the trade if implemented in its current form, they conclude.

Guidance should be substantially rewritten

However, it could be salvaged if the FDA…

  • Accepts industry grandfathered lists as a “rebuttable presumption of grandfatheredstatus​” – rather than requiring each firm to prove its products contain only pre-DSHEA dietary ingredients.
  • Ditches its insistence on multiple end-product specific notifications.
  • Scraps calls for food additive-style testing requirements.
  • Opens up the definition of which processes do NOT constitute chemical alteration.
  • Clarifies which bacterial micro-organisms are considered to be dietary ingredients and clarifies that probiotics are permitted dietary ingredients as long as they are not proven by the FDA to be unsafe.
  • Revises its view that synthetic botanical constituents, even if they are chemically identical to their ‘natural’ counterparts - are not dietary ingredients and instead evaluates them on a case-by-case on safety grounds.
  • Reconsiders its view that ingredients in an investigational new drug (IND) application cannot be dietary ingredients unless first marketed as dietary ingredients.

Click here​ to read the FDA's July 5 guidance document.

Click here​ to watch the FDA's Dan Fabricant defend the guidance at the SupplySide West show in Las Vegas.

Related topics: Regulation

Related news

Show more

1 comment

Reject NDI outright

Posted by Bill Sardi,

More insanity. Even with these stipulations posed by NPA it is practically impossible to meet the toxicity and teratogen testing requirements the new guideline proposes. My estimate these tests would require 20 years of all the profits made by the industry to get the testing done. The FDA does not even have the manpower to evaluate 50,000 products in a timely manner. It is a bureaucrats delight and an industry nightmare. NDI should be rejected outright. How can you make supplements safer than they already are (safer than table salt, aspirin, tap water, vaccines)?

Report abuse

Follow us

Products

View more

Webinars